Intestinal gene expression analysis in patients with varying grades of GVHD may provide insights into the role of cytosolic nucleic acid sensors and open the way for prospective studies using RIG-I agonists, which are currently being developed for clinical application. The gene discussed is RIGI; the disease is graft versus host disease.